These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9574074)

  • 1. [The drug. Composition, Galenic forms and ways of administration].
    Hémidy PY; Woronoff-Lemsi MC
    Soins; 1998; (622):49-50. PubMed ID: 9574074
    [No Abstract]   [Full Text] [Related]  

  • 2. [Galenic aspects of drug effects].
    Speiser P
    Pharm Acta Helv; 1966 Jun; 41(6):321-42. PubMed ID: 5963133
    [No Abstract]   [Full Text] [Related]  

  • 3. Compounding in Clinical Avian Practice.
    Pollock C
    J Avian Med Surg; 2016 Jun; 30(2):196-202. PubMed ID: 27315389
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anatomophysiological bases of drug administration. Dosage forms and routes of administration].
    Carillo Norte JA; Gañán Presmanes Y
    Rev Enferm; 2010 Dec; 33(12):28-32, 35-9. PubMed ID: 21322186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The galenic pharmacy in the development of new drugs].
    Delattre L
    Bull Mem Acad R Med Belg; 2007; 162(1-2):141-7; discussion 148-50. PubMed ID: 17821973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [It must be possible to administer a prescribed drug].
    Sjöqvist M
    Lakartidningen; 1997 Oct; 94(42):3710. PubMed ID: 9411123
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of the performances of Unguator mixing equipments for the pharmaceutical compounding of dermatological dosage forms].
    Stassen T; Piette M; Kinget R; Delattre L
    J Pharm Belg; 2006; 61(1):1-10. PubMed ID: 16669341
    [No Abstract]   [Full Text] [Related]  

  • 8. [The rate of solubility in fixed dosage forms for oral use. I].
    Polderman J; de Blaey CJ; Weekers-Andersen AB
    Pharm Weekbl; 1972 Sep; 22(38):601-10 contd. PubMed ID: 4640607
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of unlicensed and off-label medicines in the neonate.
    Conroy S; McIntyre J
    Semin Fetal Neonatal Med; 2005 Apr; 10(2):115-22. PubMed ID: 15701577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The rate of solubility in fixed dosage forms for oral use. II].
    Polderman J; de Blaey CJ; Weekers-Andersen AB
    Pharm Weekbl; 1972 Sep; 107(39):613-23 contd. PubMed ID: 4641988
    [No Abstract]   [Full Text] [Related]  

  • 11. [Topical therapy in dermatology: pharmaceutical forms, excipients and bases for magistral preparations].
    Vennat B; Pouget MP; Pourrat A
    Ann Dermatol Venereol; 2000 Jan; 127(1):110-21. PubMed ID: 10717577
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic systems--possibilities and limits].
    Meinertz T; Jähnchen E; Just H
    Verh Dtsch Ges Inn Med; 1988; 94():436-41. PubMed ID: 3144813
    [No Abstract]   [Full Text] [Related]  

  • 13. Guidelines on combination products.
    Va Med Mon (1918); 1972 Feb; 99(2):168. PubMed ID: 5066741
    [No Abstract]   [Full Text] [Related]  

  • 14. [For children the royal way, the oral way].
    Bregetzer J
    Rev Infirm; 1987 Mar; 37(6):41-3. PubMed ID: 3645756
    [No Abstract]   [Full Text] [Related]  

  • 15. [Making the administration of dry oral forms of cytotoxic medications safer].
    Legros MH; Bourget P; Demirdjian S; Osmond S; Hartmann O
    Therapie; 1999; 54(4):485-7. PubMed ID: 10667115
    [No Abstract]   [Full Text] [Related]  

  • 16. The physical and chemical problems inherent in the formulation of dosage forms for new pharmaceuticals. I.
    Macek TJ
    Am J Pharm Sci Support Public Health; 1965; 137(6):217-38 contd. PubMed ID: 5853206
    [No Abstract]   [Full Text] [Related]  

  • 17. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories.
    Jimenez FA
    Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711
    [No Abstract]   [Full Text] [Related]  

  • 18. [Nursing practices about preparation and administration of oral solutions in psychiatry].
    Le Meur-Ringard C; Gaudoneix-Taieb M; Beauverie P
    Therapie; 2007; 62(6):489-98. PubMed ID: 18316015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [How to withdraw from multi-high-dose drug therapy for schizophrenia].
    Ishigooka J
    Seishin Shinkeigaku Zasshi; 2006; 108(6):597-8. PubMed ID: 16910536
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical tolerance of calcitonin as a function of the mode of administration. Value of non-injectable forms].
    Eisinger J
    Rev Rhum Mal Osteoartic; 1987 Jan; 54(1):65-7. PubMed ID: 3563370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.